JSPR

2.51

4.58% 0.11

Handel nachbörslich: 2.42 -0.09 -3.59%

Jasper Therapeutics Inc (JSPR)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Schlusskurs vom Vortag:

$2.40

Offen:

$2.37

24-Stunden-Volumen:

451.11K

Relative Volume:

1.44

Marktkapitalisierung:

$40.80M

Einnahmen:

Nettoeinkommen (Verlust:

$-64.47M

KGV:

-0.4058

EPS:

-6.1852

Netto-Cashflow:

$-52.33M

1W Leistung:

+3.29%

1M Leistung:

+3.29%

6M Leistung:

-40.24%

1J Leistung:

-84.86%

1-Tages-Spanne:

$2.33

$2.51

1-Wochen-Bereich:

$2.29

$2.5699

52-Wochen-Spanne:

$2.215

$26.05

Jasper Therapeutics Inc Stock (JSPR) Company Profile

Firmenname

Jasper Therapeutics Inc

Sektor

Healthcare (1140)

Branche

Biotechnology (636)

Telefon

(650) 549-1400

Adresse

2200 BRIDGE PKWY SUITE #102, REDWOOD CITY

Mitarbeiter

Twitter

Nächster Verdiensttermin

2024-11-07

Neueste SEC-Einreichungen

JSPR's Discussions on Twitter

Vergleichen Sie JSPR mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
JSPR Jasper Therapeutics Inc	2.51	67.02M	0	-64.47M	-52.33M	-6.1852
VRTX Vertex Pharmaceuticals Inc	412.22	104.45B	11.39B	3.64B	3.50B	13.99
ALNY Alnylam Pharmaceuticals Inc	469.36	60.95B	2.46B	-319.09M	-52.09M	-2.4669
REGN Regeneron Pharmaceuticals Inc	572.60	59.11B	14.21B	4.46B	3.56B	39.69
ARGX Argen X Se Adr	812.95	49.23B	3.06B	1.28B	447.35M	19.67
ONC Beone Medicines Ltd Adr	320.94	35.92B	4.56B	-176.77M	225.30M	-1.7177

Jasper Therapeutics Inc Stock (JSPR) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-07-08	Herabstufung	BMO Capital Markets	Outperform → Market Perform
2025-07-08	Herabstufung	RBC Capital Mkts	Outperform → Sector Perform
2025-07-07	Herabstufung	Cantor Fitzgerald	Overweight → Neutral
2025-07-07	Herabstufung	William Blair	Outperform → Mkt Perform
2025-02-13	Eingeleitet	UBS	Buy
2024-12-06	Eingeleitet	BMO Capital Markets	Outperform
2024-09-09	Eingeleitet	JMP Securities	Mkt Outperform
2024-07-08	Eingeleitet	BTIG Research	Buy
2024-06-27	Eingeleitet	Stifel	Buy
2024-05-06	Eingeleitet	H.C. Wainwright	Buy
2024-04-03	Eingeleitet	Evercore ISI	Outperform
2024-03-28	Eingeleitet	RBC Capital Mkts	Outperform
2024-03-18	Eingeleitet	TD Cowen	Outperform
2023-08-11	Eingeleitet	CapitalOne	Overweight
2022-02-28	Eingeleitet	Cantor Fitzgerald	Overweight
2021-11-08	Eingeleitet	Credit Suisse	Outperform
2021-10-21	Eingeleitet	William Blair	Outperform
2021-10-20	Eingeleitet	BMO Capital Markets	Outperform
2021-10-13	Eingeleitet	Oppenheimer	Outperform

Alle ansehen

Jasper Therapeutics Inc Aktie (JSPR) Neueste Nachrichten

09:51 AM

Jasper Therapeutics : Corporate Presentation October 2025 - MarketScreener

09:51 AM

Oct 13, 2025

JSPR Investors Have Opportunity to Lead Jasper Therapeutics, Inc. Securities Fraud Lawsuit - PR Newswire

Oct 13, 2025

ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Jasper - GlobeNewswire

Oct 13, 2025

Celldex Therapeutics: Caution Warranted After Big Rebound (Rating Downgrade) (NASDAQ:CLDX) - Seeking Alpha

Oct 13, 2025

Pomerantz Law Firm Announces the Filing of a Class Action Against Jasper Therapeutics, Inc. and Certain OfficersJSPR - PR Newswire

Oct 13, 2025

JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Oct 13, 2025

Oct 12, 2025

JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper - GlobeNewswire

Oct 12, 2025

JSPR INVESTOR NOTICE: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper - GlobeNewswire Inc.

Oct 12, 2025

Oct 11, 2025

Bragar Eagel & Squire, P.C. Reminds Investors of Jasper, KBR, Spirit Aviation, and Molina to Contact the Firm About their Rights in Filed Class Action Lawsuits - GlobeNewswire

Oct 11, 2025

Oct 10, 2025

Deadline Alert: Jasper Therapeutics, Inc. (JSPR) Shareholders Who Lost Money Urged To Contact Glancy Prongay & Murray LLP About Securities Fraud Lawsuit - GlobeNewswire

Oct 10, 2025

JSPR INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces That Jasper Therapeutics, Inc. Investors With Substantial Losses Have Opportunity to Lead Class Action Lawsuit - FinancialContent

Oct 10, 2025

Positive Signs As Multiple Insiders Buy Jasper Therapeutics Stock - Yahoo Finance

Oct 10, 2025

Oct 09, 2025

Portnoy Law Firm Announces Class Action on Behalf of Jasper Therapeutics, Inc. Investors - GlobeNewswire

Oct 09, 2025

JSPR INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Jasper Therapeutics, Inc. Shareholders with Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Oct 09, 2025

What analysts say about Jasper Therapeutics Inc Equity Warrant stockCup and Handle Formations & Rapid Capital Trading Tips - earlytimes.in

Oct 09, 2025

Oct 08, 2025

DEADLINE ALERT for CYTK, NX, JSPR, and KBR: The Law Offices - GlobeNewswire

Oct 08, 2025

JSPR DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Jasper - GlobeNewswire

Oct 08, 2025